Curcumin as adjuvant therapy to improve remission in myeloma patients: A pilot randomized clinical trial

Curcumin as adjuvant therapy to improve remission in myeloma patients: A pilot randomized clinical trial

Background: The treatment for ineligible transplant multiple myeloma is melphalan prednisone. Curcumin has an anti-inflammatory and antiangiogenesis in cancer-directed to nuclear factor-kappa B (NF-kB) pathway. Interleukin 6 (IL-6), vascular endothelial growth factor  (VEGF), tumor necrosis factor-a...

Full description

Saved in:
Bibliographic Details
Main Authors: Damai Santosa (Author), Catharina Suharti (Author), Ignatius Riwanto (Author), Edi Dharmana (Author), Eko Adhi Pangarsa (Author), Budi Setiawan (Author), Suyono Suyono (Author), Mika Lumban Tobing (Author), Suhartono Suhartono (Author), Soeharyo Hadisaputro (Author)
Format: Book
Published: Babol University of Medical Sciences, 2022-02-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items